GR3018299T3 - Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments. - Google Patents

Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments.

Info

Publication number
GR3018299T3
GR3018299T3 GR950403417T GR950403417T GR3018299T3 GR 3018299 T3 GR3018299 T3 GR 3018299T3 GR 950403417 T GR950403417 T GR 950403417T GR 950403417 T GR950403417 T GR 950403417T GR 3018299 T3 GR3018299 T3 GR 3018299T3
Authority
GR
Greece
Prior art keywords
quinolizine
manufacture
quinolizinone
medicaments
derivatives
Prior art date
Application number
GR950403417T
Other languages
English (en)
Inventor
Maurice W Gittos
Francis P Miller
Stephen M Sorensen
John R Fozard
Paul Moser
Michael G Palfreyman
Hsien C Cheng
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP88400417A external-priority patent/EP0329904A1/en
Priority claimed from EP88400416A external-priority patent/EP0329903A1/en
Priority claimed from EP88400418A external-priority patent/EP0329905A1/en
Priority claimed from EP88400415A external-priority patent/EP0329902A1/en
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of GR3018299T3 publication Critical patent/GR3018299T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GR950403417T 1988-02-23 1995-12-05 Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments. GR3018299T3 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP88400417A EP0329904A1 (en) 1988-02-23 1988-02-23 Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of anxiety
EP88400416A EP0329903A1 (en) 1988-02-23 1988-02-23 Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of glaucoma
EP88400418A EP0329905A1 (en) 1988-02-23 1988-02-23 Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for increasing gastric motility
EP88400415A EP0329902A1 (en) 1988-02-23 1988-02-23 Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of psychosis
US18563188A 1988-04-26 1988-04-26

Publications (1)

Publication Number Publication Date
GR3018299T3 true GR3018299T3 (en) 1996-03-31

Family

ID=27513624

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950403417T GR3018299T3 (en) 1988-02-23 1995-12-05 Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments.

Country Status (10)

Country Link
EP (1) EP0329932B1 (el)
JP (1) JPH02288880A (el)
KR (1) KR890013018A (el)
AT (1) ATE129153T1 (el)
AU (1) AU624115B2 (el)
DE (1) DE68924545T2 (el)
DK (1) DK175643B1 (el)
ES (1) ES2080727T3 (el)
GR (1) GR3018299T3 (el)
IE (1) IE72504B1 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU631632B2 (en) * 1989-04-21 1992-12-03 Novartis Ag Therapeutic use of 5-ht3 receptor antagonists
EP0492020A1 (en) * 1990-12-21 1992-07-01 Merrell Dow Pharmaceuticals Inc. Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders
US5508287A (en) * 1992-02-24 1996-04-16 Merrell Pharmaceuticals Inc. 2,6-methano-2H-quinolizin derivative as 5-HT3 -receptor antagonist
NZ249346A (en) * 1992-02-24 1995-10-26 Merrell Dow Pharma 2,6-methano-2h-quinolizine ester derivatives and medicaments thereof
CA2679870A1 (en) * 2007-03-23 2008-10-02 Abbott Laboratories Azaadamantane ester and carbamate derivatives and methods of use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
DE3429830A1 (de) * 1983-08-26 1985-03-07 Sandoz-Patent-GmbH, 7850 Lörrach Automatische carbonsaeure- und sulfonsaeureester oder -amide
FR2557110B1 (fr) * 1983-12-23 1989-11-24 Sandoz Sa Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments
DE3680123D1 (en) * 1985-01-23 1991-08-14 Glaxo Group Ltd Tetrahydrocarbazolonderivate.
DE3689974T2 (de) * 1985-03-14 1994-11-03 Beecham Group Plc Arzneimittel zur Behandlung von Emesis.
GB8525913D0 (en) * 1985-10-21 1985-11-27 Beecham Group Plc Compounds
GB8511988D0 (en) * 1985-05-11 1985-06-19 Beecham Group Plc Compounds
GB8520616D0 (en) * 1985-08-16 1985-09-25 Beecham Group Plc Compounds
GB8523211D0 (en) * 1985-09-19 1985-10-23 Beecham Group Plc Compounds
EP0220011A3 (en) * 1985-10-12 1990-01-03 Beecham Group Plc Use of azabicloalkylbenzamides in the treatment of gastrointestinal motility disorders, migraine, emesis, cluster headaches, trigeminal neuralgia and arrhythmia
US4910193A (en) * 1985-12-16 1990-03-20 Sandoz Ltd. Treatment of gastrointestinal disorders
ZA878096B (en) * 1986-11-03 1988-04-26 Merrell Dow Pharmaceuticals Inc. Esters of hexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one and related compounds
EP0330788A1 (en) * 1988-03-01 1989-09-06 Merrell Dow Pharmaceuticals Inc. Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia

Also Published As

Publication number Publication date
ES2080727T3 (es) 1996-02-16
EP0329932A3 (en) 1992-08-05
EP0329932B1 (en) 1995-10-18
DE68924545T2 (de) 1996-03-21
AU3021489A (en) 1989-08-24
KR890013018A (ko) 1989-09-20
JPH02288880A (ja) 1990-11-28
IE890564L (en) 1989-08-23
DE68924545D1 (de) 1995-11-23
DK80989A (da) 1989-08-24
AU624115B2 (en) 1992-06-04
ATE129153T1 (de) 1995-11-15
IE72504B1 (en) 1997-04-23
DK175643B1 (da) 2005-01-03
DK80989D0 (da) 1989-02-22
EP0329932A2 (en) 1989-08-30

Similar Documents

Publication Publication Date Title
HUT49113A (en) Process for producing 2-/2-hydroxy-3-phenoxy-propyl-amino/-ethyl-phenoxy-methyl-amido derivatives and pharmaceutical compositions containing them as active components
NO875378D0 (no) Fremgangsmaate for fremstilling av grannlocyttstimulerende faktor (polypeptidderivater).
LTIP919A (en) Drugs and process for preparing thereof
FI892762A0 (fi) Foerfarande foer framstaellning av estrogenprodukt.
YU69289A (en) Substituted flavonoidic compounds, their salts and process for producing thereof
DK217588D0 (da) 17beta-(cyclopropylamino)-androst-5-en-3beta-olderivater, deres fremstilling og anvendelse som laegemidler
GR3001559T3 (en) Polyoxygenated labdane derivatives, process for their preparation and their use as medicaments
GR3018299T3 (en) Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments.
DE3379268D1 (en) 1'-(3-(1,2-benzisoxazol-3-yl)propyl)spiro-(benzofuran-2-(3h),3' or 4'-piperidine or 3'-pyrrolidines), a process for their preparation and their use as medicaments
GR3015297T3 (en) Improvements in and relating to serotonin antagonists.
GB2220352B (en) Medicaments for the treatment of emesis
MY105555A (en) Heterocyclicguanidines as 5ht 3 antagonists.
DK557189A (da) 1,2,3,4-tetrahydro-1,9-acridindiaminer, deres fremstilling og anvendelse som laegemidler
DK429788D0 (da) Thieno(2,3-beta)thiophen-2-sulfonamid og farmaceutisk praeparat indeholdende en saadan forbindelse
GB2216414B (en) Medicaments for the treatment of emesis
EP0333201A3 (en) Human heat shock factor
NO171211C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner
PT75727A (en) 8-<3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl>-1-phenyl-1,3,8-triazaspiro<4,5>decan-4-ones a process for the preparation thereof and their use as medicaments
EP0297570A3 (en) 2,2-bis-(3-aminophenyl)-hexafluoropropane derivatives and process for the preparation of 2,2-bis-(3,4-diaminophenyl)-hexafluoropropane
EP0458537A3 (en) Therapeutic compound for the treatment of bronchitis
HUT59307A (en) Process for producing pharmaceutical compositions comprising zofenopril and suitable for treating arthritis
AU4693789A (en) Novel Derivatives of 1,7-(imidazo-(1,2-a)pyridine)5'-6'H) ones
CS39189A2 (en) Method of tetrahydropyridine derivatives production
ES2013877A6 (es) Nuevo procedimiento para producir derivados de imidazopiridina.
YU119788A (en) Process for producing calcium 10-propyl-2,8-bis (1h-tetrazol-5-yl)-4h,6h-benzo (1,2-6,5,4-b')